Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Sales | 8,041 | 7,515 | 8,087 | 10,591 | 9,898 |
| Cost of Goods | 1,530 | 1,580 | 1,920 | 3,610 | 2,560 |
| Gross Profit | 6,500 | 5,930 | 6,160 | 6,990 | 7,330 |
| Operating Expenses | 10,160 | 11,230 | 11,110 | 8,730 | 12,990 |
| Operating Income | -3,119 | -4,715 | -4,023 | -1,139 | -5,092 |
| Interest Expense | 0 | 0 | 0 | 100 | 0 |
| Other Income | -191 | 385 | 123 | 359 | -58 |
| Pre-tax Income | -3,310 | -4,330 | -3,900 | -880 | -5,150 |
| Income Tax | 20 | -40 | 120 | 4,810 | -1,770 |
| Net Income Continuous | -3,339 | -4,290 | -4,024 | -5,697 | -3,382 |
| Net Income | $-3,339 | $-4,290 | $-4,024 | $-5,697 | $-3,382 |
| EPS Basic Total Ops | -0.14 | -0.18 | -0.17 | -0.23 | -0.14 |
| EPS Basic Continuous Ops | -0.14 | -0.18 | -0.17 | -0.23 | -0.14 |
| EPS Diluted Total Ops | -0.14 | -0.18 | -0.17 | -0.23 | -0.14 |
| EPS Diluted Continuous Ops | -0.14 | -0.18 | -0.17 | -0.23 | -0.14 |
| EBITDA(a) | $-1,979 | $-3,575 | $-2,783 | $691 | $-3,972 |